by 
The artificial kidney market is estimated for strong growth driven by the increasing prevalence of chronic kidney diseases and end-stage renal diseases globally. Artificial kidneys or dialysis machines are medical devices that filter waste products from the blood of patients suffering from kidney failure by mimicking the functions of human kidneys. They help remove toxins and excess fluid from patients’ blood and maintain proper electrolyte and acid-base balance in the body.
The artificial kidney also regulates blood pressure and produces hormones. The Global Artificial Kidney Market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE & Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies. Key players are focusing on R&D activities to develop compact portable devices by downsizing technology for home hemodialysis.
The growing prevalence of end-stage renal disease globally is a major driver of demand in the artificial kidney market. According to stats, around 2 Mn people die annually due to lack of access to dialysis and kidney transplantation. Technological innovations are helping expand access to dialysis and kidney replacement therapies.
The artificial kidney market is also witnessing increased global expansion driven by new product launches, partnerships and rising healthcare investments in developing regions. For instance, DaVita partnered with Singapore General Hospital to advance home therapies for kidney disease patients in Asia.
Market Key Trends
Miniaturization of artificial kidneys is a major trend in the market. Researchers are focusing on developing miniature wearable and implantable artificial kidneys to help patients maintain normal lifestyles without the restrictions of regular visits to dialysis centers. For instance, the implanted abdominal artificial kidney by AWAK technologies under clinical trials can perform filtration inside the body and eliminate dialysis visits.
Porter’s Analysis
Threat of new entrants: New companies will find it difficult due to high capital investment required.
Bargaining power of buyers: Buyers have low bargaining power as there are limited companies offering artificial kidneys.
Bargaining power of suppliers: Suppliers have some bargaining power as components require technical expertise.
Threat of new substitutes: Potential threat from stem cell technology and organ printing.
Competitive rivalry: Intense competition between existing players to gain market share.
The North American region dominated the artificial kidney market in 2024, with a share of over 45%. Significant prevalence of chronic kidney diseases, large patient pool of kidney failure, and availability of advanced healthcare facilities have aided the growth of the regional market.
The Asia Pacific region is expected to witness the highest growth during the forecast period. Rapidly growing geriatric population, rising incidence of diabetes and hypertension, increasing healthcare expenditure, and improving healthcare infrastructure are likely to boost market growth in the region. Countries such as China and India are expected to offer lucrative opportunities for market players.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
